WebCarcinoma, Ovarian Epithelial / genetics* DNA Mismatch Repair / genetics* Female Genetic Predisposition to Disease* Genome-Wide Association Study Germ-Line … WebJun 8, 2024 · The Gynecologic Cancer InterGroup (GCIG) International Collaboration on Ovarian Neoplasms 8 (ICON8) trial was designed to assess whether the incorporation of dose-dense weekly paclitaxel into first-line treatment of epithelial ovarian cancer in a predominantly European patient group would improve survival outcomes, and also to …
Special Section: Ovarian Cancer
WebAims: The study attempted to evaluate the kinetics of changes in serum TRAIL levels as a potential predictive and prognostic factor in patients with epithelial ovarian cancer (EOC) or primary peritoneal carcinoma (PPC), eligible for an interval debulking surgery (IDS). Material and methods: 17 patients with primary inoperable EOC or PPC in FIGO Stage IIIC or IV … WebNov 14, 2024 · The purpose of this study is to assess the efficacy and safety of treatment with carboplatin/paclitaxel* PLUS pembrolizumab (MK-3475) and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary peritoneal cancer. man in the high castle germania
Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian
WebIntroduction. Ovarian cancer has the highest mortality rate of all gynecologic cancers, because its early symptoms are nonspecific, and most patients present an advanced stage of this disease during initial diagnosis. 1 In total, 52,100 new cases and 22,500 deaths are estimated to have occurred in China in 2016, representing the second highest cause of … WebNov 1, 2010 · Ovarian cancer is one of the most aggressive cancer types in women, and epithelial ovarian cancer is the most common cause of mortality among gynecologic malignancies (Cannistra 2004). Primary ovarian epithelial tumors are divided into benign, borderline, and carcinoma, which are further classified into histological subtypes, … WebNov 14, 2024 · Efficacy was evaluated in Study 0417 (NCT04296890), a single-arm trial of 106 patients with FRα positive, platinum-resistant epithelial ovarian, fallopian tube, or … korn fieldy christian